Stay updated on FRα Clinical Trial: Mirvetuximab vs. Chemo
Sign up to get notified when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.

Latest updates to the FRα Clinical Trial: Mirvetuximab vs. Chemo page
- Check2 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the detailed study record content with a minimal error screen.SummaryDifference18%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now shows a revised version tag updating from v3.6.5 to v3.6.6, reflecting a small internal update rather than any change to study content.SummaryDifference0.0%

- Check37 days agoChange DetectedThe Study Details page now includes a Study Documents section with PDF links for the Study Protocol and Statistical Analysis Plan and related MeSH terms, expanding access to the study’s documentation and terminology. This change replaces the prior error content, restoring full resources on the page.SummaryDifference100%

- Check44 days agoChange DetectedThe page now shows a new revision tag (v3.6.5) replacing the previous v3.6.4, indicating a minor update to the page. This update does not alter the study details or results.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision: v3.6.4 replaces the previous v3.6.3 as part of a minor platform update. This change updates the page's version tag but does not alter study content, eligibility criteria, or results.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision label on the page changed from Revision: v3.6.2 to Revision: v3.6.3. This indicates a newer version of the page content with no observable changes to the study details or layout.SummaryDifference0.0%

Stay in the know with updates to FRα Clinical Trial: Mirvetuximab vs. Chemo
Enter your email address, and we'll notify you when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.